Technical Analysis for RAP - Resapp Health Ltd  

Grade Last Price % Change Price Change
grade B 0.31 14.81% 0.040
RAP closed up 14.81 percent on Tuesday, November 19, 2019, on 1.62 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical RAP trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
50 DMA Resistance Bearish 14.81%
Wide Bands Range Expansion 14.81%
Oversold Stochastic Weakness 14.81%

Older signals for RAP ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Interactive chart
Profile
ResApp Health Limited is engaged in developing digital healthcare solutions to assist doctors and patients to diagnose and manage respiratory disease. The Company offers a range of solutions, such as telehealth, clinical use, direct consumer and big data insights. The Company provides point of care diagnostic solutions for telehealth companies, which is integrated into their platforms. The Company is working on applications to provide clinical quality diagnostic tests and management tools directly to consumers and healthcare providers. The Company is developing smartphone medical applications for the diagnosis and management of respiratory disease. The Company's technology is based on the premise that cough and breathing sounds carry vital information on the state of the respiratory tract. ResApp measures the severity of a range of chronic and acute diseases, such as pneumonia, asthma, bronchiolitis and chronic obstructive pulmonary disease (COPD) using this insight.
Medicine Health Smartphone Chronic Obstructive Pulmonary Disease Asthma Diagnostic Tests Medical Terminology Healthcare Providers Chronic Lower Respiratory Diseases Digital Healthcare Solutions Respiratory Disease Respiratory Therapy
Is RAP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.415
52 Week Low 0.069
Average Volume 2,372,857
200-Day Moving Average 0.1798
50-Day Moving Average 0.2859
20-Day Moving Average 0.3015
10-Day Moving Average 0.2855
Average True Range 0.0246
ADX 31.08
+DI 24.9709
-DI 25.0583
Chandelier Exit (Long, 3 ATRs ) 0.3412
Chandelier Exit (Short, 3 ATRs ) 0.3288
Upper Bollinger Band 0.3555
Lower Bollinger Band 0.2475
Percent B (%b) 0.58
BandWidth 35.820896
MACD Line -0.0061
MACD Signal Line -0.0025
MACD Histogram -0.0036
Fundamentals Value
Market Cap 204.29 Million
Num Shares 659 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -20.67
Price-to-Sales 0.00
Price-to-Book 3.29
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.378
Resistance 3 (R3) 0.373 0.347 0.366
Resistance 2 (R2) 0.347 0.329 0.349 0.362
Resistance 1 (R1) 0.328 0.319 0.338 0.333 0.359
Pivot Point 0.302 0.302 0.306 0.304 0.302
Support 1 (S1) 0.283 0.284 0.293 0.288 0.261
Support 2 (S2) 0.257 0.274 0.259 0.258
Support 3 (S3) 0.238 0.257 0.254
Support 4 (S4) 0.243